MedTrace Logo

In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance

NCT01132417 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2011-06-23

No results posted yet for this study

Summary

Observational: studies in human beings in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Subjects in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the subjects of the study.

Conditions

  • Infections, Bacterial

Interventions

DRUG

In Vitro activity of Tigecycline among key bacterial pathogens exhibiting multidrug resistance

studies in human beings in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Subjects in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the subjects of the study.

Sponsors & Collaborators

  • King Faisal University

    lead OTHER

Principal Investigators

  • Asim E Ltayeb Diab, MD, Ph D · Assist. Professor and Consultant Microbiologist

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2012-06-30
Completion
2012-07-31

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01132417 on ClinicalTrials.gov